IPO in HK

Biopharma
There are 11 products.

Biopharma

This sector provides you market resarch, import & export data, company profiles, policy and trend analysis, etc....More

  • Available

    A-Share Listed Biological Products Companies - Profiles and Financial Data

    In China, the market size exceeded CNY 130 billion in 2016, but its share in the pharmaceutical market was less than 10%, far below that in developed countries.

    $ 1,600

    Add to cart View
  • Available

    Research Report on China Blood Product Industry, 2011-2016

    In 2015, 8,000 tons of blood plasma was needed to meet the demand of Chinese market, and the actual supply was only 5,000 tons.

    $ 2,400

    Add to cart View
  • Available

    Investigation Report on China Rituximab Market, 2009-2018

    By the first quarter of 2014, there were no products from local manufacturers on the market, which was completely occupied by Roche. Early 2014, monoclonal antibody drug "recombinant human-mouse chimeric anti-CD20 monoclonal antibody injection" produced by Hisun was approved clinical.

    $ 1,800

    Add to cart View
  • Available

    Investigation Report on China Telmisartan Market, 2009-2018

     In 2013, market size of antihypertensive prescription drug in China exceeded CNY 20 billion, increased more than 15% YOY. This has shown great potential of Chinese market.

    $ 1,800

    Add to cart View
  • Available

    Investigation Report on China Insulin Glargine Market, 2009-2018

    According to statistics from IDF (International Diabetes Federation), the global prevalence rate of diabetes among adults aged 20 to 79 was 8.3% in 2013. The number of diabetes patients has reached 382 million, of which 80% are from medium- and low-income countries where it is still rising rapidly.

    $ 1,800

    Add to cart View
  • Available

    Investigation Report on China Bevacizumab Market, 2009-2018

    The market investigation of CRI manifests that the sales value of Avastin in certain Chinese sample hospitals in 2010 was merely CNY 10 million, growing rapidly. It broke through CNY 200 million in 2013.

    $ 1,800

    Add to cart View
  • Available

    Investigation Report on China Montelukast Market, 2009-2018

    According to CRI's investigation on certain sample hospital market in China, the CAGR of sales value of montelukast surpassed 45% from 2005 to 2010. As more competitors entered the market, Chinese montelukast market growth has slowed down since 2011. However, an annual growth rate of 10% is still maintained.

    $ 1,800

    Add to cart View
  • Available

    Investigation Report on China Budesonide Market, 2009-2018

    According to CRI's market investigation, budesonide products in Chinese market are still mainly imported drugs from Astra Zeneca, but there are already some Chinese enterprises, such as Lunan Better Pharmaceutical Co., Ltd., Humanwell Healthcare (Group) Co., Ltd. and Shanghai Sine Promod Pharmaceutical Co., Ltd.,...

    $ 1,800

    Add to cart View
  • Available

    Investigation Report on China Duloxetine Market, 2009-2018

    Depression is a common mood disorder that belongs to high-incidence mental diseases worldwide. In China, antidepressants are still niche products. According to CRI's investigation, market size of antidepressant in China was less than CNY 4 billion in 2013.

    $ 1,800

    Add to cart View
  • Research Report on Global and China Blood Product Industry, 2013-2017
    Available

    Research Report on Global and China Blood Product Industry, 2013-2017

    Blood products are made by separating and extracting various proteins in plasma and classified into albumin products, immune globulin products, coagulation factor products and other blood products. China enterprises mainly produce…

    $ 2,200

    Add to cart View
  • Research Report on Global and China Monoclonal Antibody Industry, 2013-2017
    Available

    Research Report on Global and China Monoclonal Antibody Industry, 2013-2017

    Antibody drugs are usually generated from monoclonal antibody through genetic engineering, with the advantages of strong targeting, few side effects, etc. With rather promising application prospect in clinic treatment, antibody dr…

    $ 2,200

    Add to cart View